-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 12, 2019, the Guidelines for On-site Inspection of Vaccine Production (Draft for Comments) were published.
National Vaccine Inspection Center and the State Drug Administration Food and Drug Audit and Inspection Center official website issued the first on-site inspection guidelines for vaccine production.
, November 20, 2019 Premier Li Keqiang presided over an executive meeting of the State Council in Beijing on November 20, 2019.
meeting noted that by the end of next year, the first to achieve vaccines and national centralized procurement of drugs using "one thing, one yard", and can be independently checked by the public.
vaccine is a national strategic, public welfare products, related to the people's drug safety.
From the evolution of the following regulations can be seen from the vaccine regulations from nothing, the process of gradual improvement: 1, the evolution of regulations: 2, the guidelines related to vaccines: September 2, 2019, the State Drug Administration Drug Review Center published on the official website of the "vaccine after the market production process change technical guidelines" (draft for comments), to fill China's vaccine after the market production process change technology in the regulatory, technical level of the gap.
.
